Comparison of different kinetic models for dynamic 18F-FDG PET/CT imaging of hepatocellular carcinoma with various, also dual-blood input function

被引:15
作者
Geist, Barbara Katharina [4 ]
Wang, Jingnan [1 ,2 ,3 ]
Wang, Xuezhu [1 ,2 ,3 ]
Lin, Jianzhen [2 ,5 ]
Yang, Xu [2 ,5 ]
Zhang, Hui [6 ]
Li, Fang [1 ,2 ,3 ]
Zhao, Haitao [2 ,5 ]
Hacker, Marcus [4 ]
Huo, Li [1 ,2 ]
Li, Xiang [4 ]
机构
[1] Chinese Acad Med Sci, Dept Nucl Med, Beijing, Peoples R China
[2] Peking Union Med Coll Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Beijing Key Lab Mol Targeted Diag & Therapy Nucl, Beijing, Peoples R China
[4] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Div Nucl Med, Vienna, Austria
[5] Chinese Acad Med Sci, Dept Liver Surg, Beijing, Peoples R China
[6] Tsinghua Univ, Dept Biomed Engn, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
FDG; positron emission tomography; hepatocellular carcinoma; dual input function; kinetic model; POSITRON-EMISSION-TOMOGRAPHY;
D O I
10.1088/1361-6560/ab66e3
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
A kinetic modeling analysis was performed on hepatocellular carcinoma (HCC) as well as healthy liver tissue regions from dynamic FDG positron emission tomographys/computer tomography (PET/CT) cans. On basis of image derived input function from hepatic artery and portal vein, various kinetic models were compared among each other in order to check whether HCC can be classified and differ from healthy tissue within the kinetic parameters. 14 HCC and 10 healthy liver regions from FDG PET/CT scans of ten patients were analyzed from their time activity curves (TACs) were extracted from the PET dynamic images. Also the hepatic artery and the portal vein were delineated in the fused PET/CT images, which were used as input functions. Four kinetic models were applied to the TACs, using both or only one input function. Results were analyzed with several information criteria according to Akaike and Schwartz as well as be the F-Test. The paired student's t-test was used to determine the differences between HCC and healthy regions. All applied models revealed significant differences of p < 0.01 of k(3) between HCC and healthy liver and three out of four models produced almost identical values for k(3) = 0.03 min(-1) and K-i = 0.03 min(-1). According to the information criteria tests, a simple two-tissue model with only a venous input function is clearly preferred in case of HCC TACs. After dividing all HCC regions into two groups having a low and a high HCC-to-healthy ratio, respectively, this model also showed significant differences of k(3) between these two groups. In conclusion, results indicate that the portal vein is sufficient to describe kinetic FDG processes in HCC and healthy liver regions.
引用
收藏
页数:9
相关论文
共 23 条
[1]   The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015 [J].
Akinyemiju, Tomi ;
Abera, Semaw ;
Ahmed, Muktar ;
Alam, Noore ;
Alemayohu, Mulubirhan Assefa ;
Allen, Christine ;
Al-Raddadi, Rajaa ;
Alvis-Guzman, Nelson ;
Amoako, Yaw ;
Artaman, Al ;
Ayele, Tadesse Awoke ;
Barac, Aleksandra ;
Bensenor, Isabela ;
Berhane, Adugnaw ;
Bhutta, Zulfiqar ;
Castillo-Rivas, Jacqueline ;
Chitheer, Abdulaal ;
Choi, Jee-Young ;
Cowie, Benjamin ;
Dandona, Lalit ;
Dandona, Rakhi ;
Dey, Subhojit ;
Dicker, Daniel ;
Phuc, Huyen ;
Ekwueme, Donatus U. ;
Zaki, Maysaa El Sayed ;
Fischer, Florian ;
Furst, Thomas ;
Hancock, Jamie ;
Hay, Simon I. ;
Hotez, Peter ;
Jee, Sun Ha ;
Kasaeian, Amir ;
Khader, Yousef ;
Khang, Young-Ho ;
Kumar, G. Anil ;
Kutz, Michael ;
Larson, Heidi ;
Lopez, Alan ;
Lunevicius, Raimundas ;
Malekzadeh, Reza ;
McAlinden, Colm ;
Meier, Toni ;
Mendoza, Walter ;
Mokdad, Ali ;
Moradi-Lakeh, Maziar ;
Nagel, Gabriele ;
Nguyen, Quyen ;
Nguyen, Grant ;
Ogbo, Felix .
JAMA ONCOLOGY, 2017, 3 (12) :1683-1691
[2]   Noninvasive quantification of the cerebral metabolic rate for glucose using positron emission tomography, 18F-fluoro-2-deoxyglucose, the Patlak method, and an image-derived input function [J].
Chen, K ;
Bandy, D ;
Reiman, E ;
Huang, SC ;
Lawson, M ;
Feng, D ;
Yun, LS ;
Palant, A .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (07) :716-723
[3]   Assessment of Blood Flow in Hepatocellular Carcinoma: Correlations of Computed Tomography Perfusion Imaging and Circulating Angiogenic Factors [J].
Chen, Ya-Wen ;
Pan, Huay-Ben ;
Tseng, Hui-Hwa ;
Hung, Yu-Ting ;
Huang, Jer-Shyung ;
Chou, Chen-Pin .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (09) :17536-17552
[4]   Immune checkpoint inhibitors for hepatocellular carcinoma [J].
El Dika, Imane ;
Khalil, Danny N. ;
Abou-Alfa, Ghassan K. .
CANCER, 2019, 125 (19) :3312-3319
[5]  
European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019
[6]   Assessing the kidney function parameters glomerular filtration rate and effective renal plasma flow with dynamic FDG-PET/MRI in healthy subjects [J].
Geist, Barbara K. ;
Baltzer, Pascal ;
Fueger, Barbara ;
Hamboeck, Martina ;
Nakuz, Thomas ;
Papp, Laszlo ;
Rasul, Sazan ;
Sundar, Lalith Kumar Shiyam ;
Hacker, Marcus ;
Staudenherz, Anton .
EJNMMI RESEARCH, 2018, 8
[7]   Model selection criteria for dynamic brain PET studies [J].
Golla, Sandeep S. V. ;
Adriaanse, Sofie M. ;
Yaqub, Maqsood ;
Windhorst, Albert D. ;
Lammertsma, Adriaan A. ;
van Berckel, Bart N. M. ;
Boellaard, Ronald .
EJNMMI PHYSICS, 2017, 4
[8]  
Hays MT, 1999, J NUCL MED, V40, P1358
[9]   AASLD guidelines for the treatment of hepatocellular carcinoma [J].
Heimbach, Julie K. ;
Kulik, Laura M. ;
Finn, Richard S. ;
Sirlin, Claude B. ;
Abecassis, Michael M. ;
Roberts, Lewis R. ;
Zhu, Andrew X. ;
Murad, M. Hassan ;
Marrero, Jorge A. .
HEPATOLOGY, 2018, 67 (01) :358-380
[10]  
Ho CL, 2003, J NUCL MED, V44, P213